M W Trader

411 total citations
17 papers, 217 citations indexed

About

M W Trader is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, M W Trader has authored 17 papers receiving a total of 217 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in M W Trader's work include Acute Lymphoblastic Leukemia research (4 papers), Biochemical and Molecular Research (3 papers) and Lung Cancer Treatments and Mutations (3 papers). M W Trader is often cited by papers focused on Acute Lymphoblastic Leukemia research (4 papers), Biochemical and Molecular Research (3 papers) and Lung Cancer Treatments and Mutations (3 papers). M W Trader collaborates with scholars based in United States. M W Trader's co-authors include F. M. Schabel, Daniel P. Griswold, Howard E. Skipper, J. Thomson, Steadman D. Harrison, W R Laster, Robert F. Struck, Thomas H. Corbett, William J. Suling and Donald J. Dykes and has published in prestigious journals such as British Journal of Cancer, Biochemical Pharmacology and Cancer Treatment Reviews.

In The Last Decade

M W Trader

14 papers receiving 186 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M W Trader United States 7 101 77 35 34 27 17 217
DR Newell United Kingdom 9 108 1.1× 88 1.1× 48 1.4× 13 0.4× 34 1.3× 12 216
George S. Tarnowski United States 12 144 1.4× 55 0.7× 25 0.7× 44 1.3× 40 1.5× 27 334
Elizabeth A. Dulmadge United States 11 226 2.2× 144 1.9× 18 0.5× 49 1.4× 20 0.7× 22 376
Dorothy H. Trites United States 11 219 2.2× 140 1.8× 18 0.5× 73 2.1× 30 1.1× 15 378
Randall W. Steinkampf United States 9 225 2.2× 159 2.1× 15 0.4× 82 2.4× 34 1.3× 13 385
M Michelson France 10 118 1.2× 78 1.0× 13 0.4× 45 1.3× 37 1.4× 18 357
Jennifer A. Banzon United States 9 208 2.1× 115 1.5× 15 0.4× 78 2.3× 28 1.0× 9 376
Glenys M. Otter United States 11 211 2.1× 99 1.3× 19 0.5× 111 3.3× 21 0.8× 24 369
Bogdan Falkiewicz Poland 10 238 2.4× 80 1.0× 16 0.5× 43 1.3× 24 0.9× 48 389
Celia G. Evans United States 6 133 1.3× 38 0.5× 15 0.4× 15 0.4× 12 0.4× 8 257

Countries citing papers authored by M W Trader

Since Specialization
Citations

This map shows the geographic impact of M W Trader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M W Trader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M W Trader more than expected).

Fields of papers citing papers by M W Trader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M W Trader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M W Trader. The network helps show where M W Trader may publish in the future.

Co-authorship network of co-authors of M W Trader

This figure shows the co-authorship network connecting the top 25 collaborators of M W Trader. A scholar is included among the top collaborators of M W Trader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M W Trader. M W Trader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Schabel, F. M., M W Trader, W R Laster, Glynn P. Wheeler, & M Witt. (2015). Patterns of Resistance and Therapeutic Synergism among Alkylating Agents1. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 23. 200–215.
2.
Harrison, Steadman D., et al.. (1987). Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivo. Investigational New Drugs. 5(4). 345–351. 11 indexed citations
3.
Wilkoff, Lee J., Elizabeth A. Dulmadge, M W Trader, Steadman D. Harrison, & Daniel P. Griswold. (1987). Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II). Cancer Chemotherapy and Pharmacology. 20(2). 96–100. 32 indexed citations
4.
Plowman, Jacqueline, et al.. (1987). Preclinical antitumor activity and pharmacological properties of deoxyspergualin.. PubMed. 47(3). 685–9. 32 indexed citations
5.
Harrison, Steadman D., Peter J. O’Dwyer, & M W Trader. (1986). Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice.. PubMed. 46(7). 3396–400. 5 indexed citations
6.
Wolpert-DeFilippes, Mary K., Jacqueline Plowman, John M. Venditti, et al.. (1986). Pleiotropic resistance and drug development.. PubMed. 223. 143–9. 4 indexed citations
7.
Struck, Robert F., Donald J. Dykes, Thomas H. Corbett, William J. Suling, & M W Trader. (1983). Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide. British Journal of Cancer. 47(1). 15–26. 33 indexed citations
8.
Schabel, F. M., et al.. (1983). Therapeutic activity of mitoxantrone and ametantrone against murine tumors. Cancer Treatment Reviews. 10. 13–21. 17 indexed citations
9.
Schabel, F. M., Daniel P. Griswold, Thomas H. Corbett, W R Laster, & M W Trader. (1983). Curative chemotherapy of advanced 239pu-induced osteosarcoma (239pu os) in mice with 2-beta-d-ribofuranosylthiazole-4- -carboxamide (t-car) and of advanced leukemia l1210 with t-car plus bcnu. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 265. 2 indexed citations
10.
Trader, M W, F. M. Schabel, W R Laster, & R W Brockman. (1983). Combination chemotherapy of ara-c-resistant leukemia p388 (p388/ara-c) with inhibitors of purine and pyrimidine biosynthesis. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 265. 2 indexed citations
11.
Schabel, F. M., Howard E. Skipper, M W Trader, et al.. (1982). Drug control of Ara-C-resistant tumor cells. Medical and Pediatric Oncology. 10(S1). 125–148. 17 indexed citations
12.
Trader, M W, et al.. (1982). Some biochemical characteristics of L1210 cell lines resistant to 6-mercaptopurine and 6-thioguanine and with increased sensitivity to methotrexate. Biochemical Pharmacology. 31(19). 3133–3137. 2 indexed citations
13.
Schabel, F. M., M W Trader, W R Laster, & M Witt. (1981). Therapeutic synergism (ts) of ara-c plus methotrexate (mtx) against murine leukemia l1210. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 214. 1 indexed citations
14.
Schabel, F. M., M W Trader, & W R Laster. (1979). CISDIAMMINE DICHLOROPLATINUM II AOMBINATION CHEMOTHERAPY AND CROSS-RESISTANCE STUDIES WITH TUMORS OF MICE. 63. 1459–1473.
15.
Schabel, F. M., W R Laster, & M W Trader. (1971). Specific dna inhibitors vs leukemia l1210. Development of resistance to ara-c and ribonucleotide reductase inhibitors. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 67. 3 indexed citations
16.
Schabel, F. M., W R Laster, & M W Trader. (1968). Therapeutic potentiation of antileukemic drugs. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 62. 1 indexed citations
17.
Skipper, Howard E., F. M. Schabel, M W Trader, & J. Thomson. (1961). Experimental evaluation of potential anticancer agents. VI. Anatomical distribution of leukemic cells and failure of chemotherapy.. PubMed. 21. 1154–64. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by DR Newell Breakdown of academic impact, for papers by George S. Tarnowski Breakdown of academic impact, for papers by Elizabeth A. Dulmadge Breakdown of academic impact, for papers by Dorothy H. Trites Breakdown of academic impact, for papers by Randall W. Steinkampf Breakdown of academic impact, for papers by M Michelson Breakdown of academic impact, for papers by Jennifer A. Banzon Breakdown of academic impact, for papers by Glenys M. Otter Breakdown of academic impact, for papers by Bogdan Falkiewicz Breakdown of academic impact, for papers by Celia G. Evans
Rankless by CCL
2026